These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33714744)

  • 21. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy.
    Golzari H; Cebul RD; Bahler RC
    Ann Intern Med; 1996 Aug; 125(4):311-23. PubMed ID: 8678396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
    Wipf JE
    West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials.
    Liew AY; Eikelboom JW; Connolly SJ; O' Donnell M; Hart RG
    Int J Stroke; 2014 Feb; 9(2):199-206. PubMed ID: 23506160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
    Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D
    PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis.
    Casula M; Fortuni F; Fabris F; Leonardi S; Gnecchi M; Sanzo A; Greco A; Rordorf R
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):570-576. PubMed ID: 32628422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Magnani G; Giugliano RP; Ruff CT; Murphy SA; Nordio F; Metra M; Moccetti T; Mitrovic V; Shi M; Mercuri M; Antman EM; Braunwald E
    Eur J Heart Fail; 2016 Sep; 18(9):1153-61. PubMed ID: 27349698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of CHADS2 score on late stroke after the Cox maze procedure.
    Pet M; Robertson JO; Bailey M; Guthrie TJ; Moon MR; Lawton JS; Rinne A; Damiano RJ; Maniar HS
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):85-9. PubMed ID: 22818126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
    Hess PL; Greiner MA; Fonarow GC; Klaskala W; Mills RM; Setoguchi S; Al-Khatib SM; Hernandez AF; Curtis LH
    Clin Cardiol; 2012 Nov; 35(11):649-57. PubMed ID: 23070696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke risk and antithrombotic strategies in atrial fibrillation.
    Medi C; Hankey GJ; Freedman SB
    Stroke; 2010 Nov; 41(11):2705-13. PubMed ID: 20930160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
    Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
    Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.